Literature DB >> 12735585

Loss of heterozygosity on the long arm of chromosome 21 in non-small cell lung cancer.

Eung Bae Lee1, Tae In Park, Sun Ha Park, Jae Yong Park.   

Abstract

BACKGROUND: In Down syndrome, the incidence of solid tumors including lung cancer is considerably lower than that of the general population. The low risk of lung cancer in individuals with Down syndrome may be related to the gene-dosage effect of the extra chromosome 21. It may suggest that tumor suppressor genes playing a role in the pathogenesis of lung cancer may be present on chromosome 21.
METHODS: A total of 39 surgically resected non-small cell lung cancers were analyzed using nine microsatellite markers for 21q. Loss of heterozygosity was considered to be present when the signal intensity of the allele in tumor DNA was less than 50% of that in the corresponding normal DNA.
RESULTS: Loss of heterozygosity for at least one locus was detected in 22 of 39 tumors (56.4%). Allelic loss was frequently detected at three distinct regions: at the locus D21S1432 on 21q21.1, the region between D21S1435 and D21S1442 on 21q21.2 to 21.3, and the region between D21S1270 and D21S1445 on 21q22.1.
CONCLUSIONS: These results indicate that loss of heterozygosity on 21q may play an important role in the pathogenesis of non-small cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735585     DOI: 10.1016/s0003-4975(02)04902-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

2.  Mapping tumor-suppressor genes with multipoint statistics from copy-number-variation data.

Authors:  Iuliana Ionita; Raoul-Sam Daruwala; Bud Mishra
Journal:  Am J Hum Genet       Date:  2006-05-30       Impact factor: 11.025

3.  Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer.

Authors:  Iñaki Valles; Maria J Pajares; Victor Segura; Elisabet Guruceaga; Javier Gomez-Roman; David Blanco; Akiko Tamura; Luis M Montuenga; Ruben Pio
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

4.  Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer.

Authors:  Romulo M Brena; Carl Morrison; Sandya Liyanarachchi; David Jarjoura; Ramana V Davuluri; Gregory A Otterson; David Reisman; Selina Glaros; Laura J Rush; Christoph Plass
Journal:  PLoS Med       Date:  2007-03-27       Impact factor: 11.069

5.  MIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma.

Authors:  Chencheng Han; Hong Li; Zhifei Ma; Guozhang Dong; Qianyun Wang; Siwei Wang; Panqi Fang; Xiang Li; Hao Chen; Tongyan Liu; Lin Xu; Jie Wang; Jun Wang; Rong Yin
Journal:  Cell Death Dis       Date:  2021-04-30       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.